Risk of myocarditis and pericarditis following coronavirus disease 2019 messenger RNA Vaccination-A nationwide study
Journal
Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi
Date Issued
2023-02-08
Author(s)
Su, Wei-Ju
Liu, Yu-Lun
Lin, Yen-Ching
Huang, Wei-I
Wu, Li-Chiu
Chen, Shu-Fong
Lin, Yu-Sheng
Hsieh, Yee-Lin
Yang, Chiao-An
Lin, Chiu-Hsiang
Chan, Kim-Wei Arnold
Chuang, Jen-Hsiang
Yang, Chin-Hui
Abstract
An extended interval between the two primary doses may reduce the risk of myocarditis/pericarditis after COVID-19 mRNA vaccination. Taiwan has implemented a two-dose regimen with a 12-week interval for adolescents. Here we present nationwide data of myocarditis/pericarditis following COVID-19 vaccinations.
Subjects
COVID-19; Myocarditis; Pericarditis; Population-based study; Vaccination
SDGs
Type
journal article